CONMED (CNMD) vs Edwards Lifesciences (EW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Edwards Lifesciences (EW) has outperformed CONMED (CNMD) over the past year, gaining 11.8% versus a loss of 3.6%. Over five years, EW leads with a -23.5% price change compared with -68.9% for CNMD. Edwards Lifesciences is the larger company by market cap ($49.44 billion vs $1.32 billion), about 37.3 times the size.
On valuation, CONMED trades at a lower forward P/E (9.3x vs 25.4x for Edwards Lifesciences). CONMED pays a dividend yielding 0.45%, while Edwards Lifesciences does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNMD | EW |
|---|---|---|
| Share price | $44.23 | $85.78 |
| Market cap | $1.32B | $49.44B |
| 1-day change | -0.56% | -0.81% |
| YTD return | +8.94% | +0.62% |
| 1-year return | -3.64% | +11.81% |
| 5-year return | -68.86% | -23.52% |
| P/E ratio (TTM) | 23.91 | 51.06 |
| Forward P/E | 9.25 | 25.40 |
| EPS (TTM) | $1.85 | $1.68 |
| Dividend yield | 0.45% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| Revenue (latest FY) | — | $6.07B |
| Revenue growth (YoY) | — | +11.55% |
| Net income (latest FY) | — | $1.07B |
| Gross margin | — | 78.01% |
| Operating margin | — | 20.84% |
| Net margin | — | 17.69% |
| 52-week high | $53.66 | $96.29 |
| 52-week low | $31.44 | $72.30 |
| Distance from 52-week high | -17.57% | -10.91% |
| Analyst consensus | none | buy |
| Avg. price target upside | +2.87% | +18.86% |
| Average volume | 493.85K | 3.82M |
| Shares outstanding | 29.95M | 576.40M |
| Employees | 3,900 | 16,000 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Edwards Lifesciences is about 37.3 times larger than CONMED by market value ($49.44B vs $1.32B).
- EW has outperformed CNMD by 15.4 percentage points over the past year.
- Edwards Lifesciences trades at a higher earnings multiple (51.1x vs 23.9x trailing P/E).
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Healthcare · Medical Devices · 3,900 employees
About Edwards Lifesciences
EW stock →Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
Healthcare · Medical Devices · 16,000 employees
CNMD vs EW FAQ
Which is bigger, CONMED or Edwards Lifesciences?
Edwards Lifesciences (EW) is larger, with a market capitalization of $49.44B compared with $1.32B for CONMED (CNMD).
Which stock has performed better over the past year, CNMD or EW?
EW returned +11.81% over the past 12 months, compared with -3.64% for CNMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CNMD or EW?
CNMD has the lower trailing P/E at 23.9, versus 51.1 for EW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CONMED or Edwards Lifesciences?
CONMED pays a dividend yielding 0.45%, while Edwards Lifesciences does not currently pay a regular dividend.
Are CONMED and Edwards Lifesciences in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.